Vascular permeability factor (Vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast
β Scribed by Anthony J. Guidi; Stuart J. Schnitt; Lars Fischer; Kathi Tognazzi; Jay R. Harris; Harold F. Dvorak; Lawrence F. Brown
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 387 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
histologic features on hematoxylin and eosin stained sections, and microvessel density and distribution using sections immunostained for factor VIII-related anti-1 Departments of Pathology, Beth Israel Deagen. In addition, in situ hybridization was performed on formalin fixed, paraffin coness Medical Center and Harvard Medical embedded sections using 35 S labeled riboprobes specific for VPF/VEGF. School, Boston, Massachusetts.
RESULTS. VPF/VEGF expression by tumor cells in DCIS was greater than that
π SIMILAR VOLUMES
## Background: Angiogenesis is essential for solid tumor growth and metastasis. vascular endothelial growth factor (vegf), a recently identified growth factor with significant angiogenic properties, may be a major tumor angiogenesis regulator in vivo. conversely, there have been few studies of the
The angiogenic factor vascular endothelial growth factor (VEGF) predicts outcome in primary breast carcinoma. Alteration of the p53 gene causes down-regulation of the expression of thrombospondin-1, a natural inhibitor of angiogenesis. This study was conducted to investigate the association between